Sfoglia per AUTORE
ASAFTEI SD
Collezione AOU Città della Salute di Torino

  

Items : 11

Identification of DNA methylation episignature for the intellectual developmental disorder, autosomal dominant 21 syndrome, caused by variants in the CTCF gene. in Genetics in medicine : official journal of the American College of Medical Genetics / Genet Med. 2024 Mar;26(3):101041. doi: 10.1016/j.gim.2023.101041. Epub 2023 Dec 3.

2024
AOU Città della Salute di Torino

Alders MM; Merla G; Brusco A; Trajkova S; Mussa A; Shukarova-Angelovska E; Carli D; Asaftei SD; Piccione M; Vissers L; Salzano E; Tedder ML; Gerkes EH; Zonneveld-Huijssoon E; Brooks A; Kerkhof J; McConkey H; Levy MA; Haghshenas S; Relator R; Karimi K; Mol MO; Bouman A; Sadikovic B;

An integrative morpho-molecular approach in malignant ectomesenchymoma diagnosis: report of a new paediatric case and a review of the literature. in Frontiers in oncology / Front Oncol. 2024 Mar 1;14:1320541. doi: 10.3389/fonc.2024.1320541. eCollection 2024.

2024
AOU Città della Salute di Torino

Asaftei SD; Linari A; Rubino C; Augustoni E; Campello A; Divincenzo F; Tirtei E; Pellegrino F; Fagioli F;

Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2). in Cancer / Cancer. 2022 May 15;128(10):1958-1966. doi: 10.1002/cncr.34131. Epub 2022 Feb 24.

2022
AOU Città della Salute di Torino

Marchesi E; Staals EL; Cesari M; D'Angelo P; Mascarin M; Perrotta S; Abate ME; Longhi A; Favre C; Bertulli R; Scotlandi K; Donati DM; Gambarotti M; Serra M; Manzitti C; Luksch R; Coccoli L; Milano GM; Asaftei SD; Ferraresi V; Tamburini A; Bisogno G; Meazza C; Palmerini E; Carretta E; Ibrahim T; Casali PG; Picci P; Fagioli F; et alii...

State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2021 Oct;22(15):1995-2006. doi: 10.1080/14656566.2021.1936499. Epub 2021 J

2021
AOU Città della Salute di Torino

Meazza C; Asaftei SD;

Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. in Cancers / Cancers (Basel). 2021 Jun 18;13(12):3046. doi: 10.3390/cancers13123046.

2021
AOU Città della Salute di Torino

Asaftei SD; Puma N; Paioli A; Petraz M; Morosi C; Podda M; Tamburini A; Palmerini E; Coccoli L; Grignani G; Manzitti C; Bertulli R; De Leonardis F; Rabusin M; Campello A; Tirtei E; Picci P; Prete A; Longhi A; Fagioli F; Luksch R;

Management of Hepatitis-B Virus Infection in Immunocompromised Children: A Single Center Experience. in Journal of pediatric gastroenterology and nutrition / J Pediatr Gastroenterol Nutr. 2021 Apr 1;72(4):597-602. doi: 10.1097/MPG.0000000000003042.

2021
AOU Città della Salute di Torino

Calvo PL; Pinon M; Dell'Olio D; Carpino A; Biasin E; Pizzol A; Catalano S; Peruzzi L; Rigazio C; Cisarò F; Opramolla A; Asaftei SD; Quarello P; Fagioli F;

Omic approaches to pediatric bone sarcomas. in Pediatric blood & cancer / Pediatr Blood Cancer. 2020 Feb;67(2):e28072. doi: 10.1002/pbc.28072. Epub 2019 Nov 17.

2020
AOU Città della Salute di Torino

Fagioli F; Asaftei SD; De Luna E; Quarello P; Cereda M; Tirtei E;

Management of Unresectable Metastatic Primitive Myxoid Mesenchymal Tumor of Infancy: A Case Report and Systematic Review of the Literature. in Journal of pediatric hematology/oncology / J Pediatr Hematol Oncol. 2020 Apr;42(3):163-169. doi: 10.1097/MPH.0000000000001764.

2020
AOU Città della Salute di Torino

Asaftei SD; Campello A; Tirtei E; Colombo S; Vallero S; Boffano M; Fagioli F;

Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis. in Tumori / Tumori. 2018 Jun;104(3):202-206. doi: 10.1177/0300891617753257.

2018
AOU Città della Salute di Torino

Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F;

Survival after Second and Subsequent Recurrences in Osteosarcoma: A Retrospective Multicenter Analysis. in Tumori / Tumori. 2017 May 1:tj5000636. doi: 10.5301/tj.5000636.

2017
AOU Città della Salute di Torino

Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F;

Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial. in The Lancet. Oncology / Lancet Oncol. 2015 Jan;16(1):98-107. doi: 10.1016/S1470-2045(14)71136-2. Epub 2014 Dec 11.

2015
AOU Città della Salute di Torino

Casali PG; Fagioli F; Gambarotti M; Biagini R; Capozzi F; Marchesi E; Sangiolo D; Pignochino Y; Tamburini A; Asaftei SD; Bertulli R; D'Ambrosio L; Ferraresi V; Palmerini E; Grignani G; Picci P; Ferrari S; Aglietta M;